LENZ
LENZ Therapeutics Inc
3.60$
-4.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | +150.0% | -87.3% | +19.7% | +188.6% | – | |
| – | – | – | – | -25.6% | +11.1% | +456.0% | +240.3% | +0.0% | +9.1% | +5.0% | +2.5% | -0.1% | -5.5% | -61.9% | -82.3% | -96.5% | +260.0% | -44.4% | +230.0% | +9.1% | -47.2% | +557.9% | +320.0% | +126.1% | -76.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -209.1% | – | +148.4% | -91.4% | -32.8% | +629.1% | – | |
| – | – | +446.1% | +176.6% | -15.9% | +135.6% | -31.5% | +29.0% | +62.8% | -2.6% | -9.2% | -52.7% | +35.3% | +22.4% | +34.5% | +14.9% | -46.1% | -34.1% | -7.1% | -9.0% | -0.9% | +55.7% | -58.2% | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +53.0% | +0.0% | +0.0% | +1.3% | +139.3% | +0.0% | +0.0% | +33.4% | -12.3% | +44.1% | +18.8% | +15.1% | +115.7% | +43.6% | +13.4% | -12.4% | – | |
| – | +966.9% | +191.6% | +117.9% | +13.1% | +87.9% | -19.4% | +34.8% | +27.1% | +2.7% | -2.9% | -61.9% | +38.2% | +18.6% | +32.8% | +25.8% | -35.6% | -10.8% | -9.8% | +17.6% | +11.0% | +29.3% | +43.2% | +26.4% | +13.5% | -12.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +618.9% | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.